BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Apoptosis, Hepatitis, Stem cell, Nosology, Rosiglitazone, rs3825942, EGFR)
Bookmark Forward

QuickView for RP1 (gene)


Body Atlas

Most Correlated Tissues

  1. Fallopian tube
  2. Peritoneum
  3. Omental adipose tissue
  4. Bladder
  5. Placenta
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hyperlipidemia
  2. Encephalomyelitis
  3. Retinal disorder
  4. Delayed hypersensitivity disorder
  5. Retinal detachment
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Zymosan
  2. Dkk1 protein, mouse
  3. Aflatoxins
  4. C-Peptide
  5. interleukin-34, mouse
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. PALB2
  2. RAPGEF3
  3. PLN
  4. NRL
  5. HNRNPU
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Identification of a novel nonsense mutation in RP1 that causes autosomal recessive retinitis pigment…
  2. In Silico identification of a common mobile element insertion in exon 4 of RP1.
  3. Biallelic RP1-associated retinal dystrophies: Expanding the mutational and clinical spectrum.
  4. A founder Alu insertion in RP1 gene in Japanese patients with retinitis pigmentosa.
  5. Maternal Uniparental Isodisomy of Chromosome 4 and 8 in Patients with Retinal Dystrophy: SRD5A3-Cong…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
  2. Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
  3. A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies
  4. The FIGHT-RP1 Study
  5. Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pig…
Explore Clinical Trials Results
  • Copyright © 2022 Illumina Inc. All rights reserved.